Target intelligence / Profile preview

Inhibitor of apoptosis protein cIAP1 (cIAP1)

Target
cIAP1
Molecular classification
Inhibitor of Apoptosis Proteins (IAPs), E3 ubiquitin ligase
01

Overview

cIAP1 is a multifunctional regulator at the intersection of cell death, survival, inflammation, and immunity. It functions as an E3 ubiquitin ligase and regulates apoptosis through ubiquitination pathways, notably by ubiquitinating RIPK1. It is involved in NF-κB signaling, MAPK pathway activation, innate immunity, and stress adaptation. Overexpression or dysregulation of cIAP1 has been observed in various cancers, contributing to tumor progression and resistance to therapy. It also plays a critical role in pancreatic β-cell survival during endoplasmic reticulum stress. As such, it represents a potential therapeutic target for cancer and other diseases.

Other names
BIRC2Baculoviral IAP Repeat Containing 2
02

Mechanism of action

IAP antagonists promote degradation of cIAP1, leading to apoptosis in cancer cells and modulation of inflammatory signaling.

03

Biological functions

Inhibition of ApoptosisE3 Ubiquitin Ligase ActivityRegulation of Signaling PathwaysNF‑κB signaling activationMAPK pathway activationImmune modulationStress adaptation
04

Disease associations

CancerDiabetesInflammatory diseases
05

Safety considerations

Dysregulation can impair tissue homeostasis due to defective regulation at the interface between cell death/inflammation signaling networks.
06

Interacting drugs

Small-molecule IAP antagonists

1 more in the full profile.

Beyond the preview

Go deeper on Inhibitor of apoptosis protein cIAP1 (cIAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inhibitor of apoptosis protein cIAP1 (cIAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call